UC Davis Health’s pediatric stem cell (bone marrow) transplant program is rejuvenated under new leadership.
Read MoreUC Davis neurologist Ricardo Maselli will lead the first MDA Kickstart project to develop a gene therapy for a rare type of congenital myasthenic syndrome, an inherited neuromuscular disease.
Read MoreUC Davis Health researchers has discovered a novel bioelectrical mechanism pathogens like Salmonella use to find entry points in the gut lining that would allow them to pass and cause infection.
Read MoreIn a Q&A, UC Davis Health physical medicine and rehabilitation specialist Maya Evans shares how clinicians and parents can provide comprehensive care for children with spinal cord injuries and spina bifida.
Read MoreA stem cell therapy for Crohn's disease developed by gastroenterology researchers has shown promising results in mouse studies.
Read MoreProfessor Aijun Wang has designed and tested a structure that can help large deep burn wounds heal faster and potentially reduce the need for skin autografting.
Read MoreFetal surgeon Diana Farmer and bioengineer Aijun Wang have been awarded $15 million by the state’s stem cell agency and Shriners Children’s to test their stem cell treatment for spina bifida.
Read MoreA Q&A with the new director of UC Davis Good Manufacturing Practice (GMP) facility Brian Fury to learn about the GMP’s plans and recent California Institute for Regenerative Medicine (CIRM) $1.7 million award.
Read MoreUC Davis exceeded $1 billion in external research funding in the fiscal year 2022–23. The School of Medicine contributed 40% of this amount, achieving a new research funding record.
Read MoreUC Davis and Orgenesis are rolling out processing units that allow cell and gene therapies to be developed and manufactured onsite. This will increase patient access to therapies.
Read MoreChair of Physical Medicine and Rehabilitation Craig McDonald was honored with a 2023 Top Ten Clinical Research Achievement Award, in recognition of his remarkable work on Duchenne muscular dystrophy.
Read MoreResearchers have begun a new stem cell clinical trial to treat patients with swallowing problems. The study takes stem cells and injects them into the patient’s tongue.
Read MoreProfessor Aijun Wang won a $2 million grant from California’s Stem Cell Agency to develop a cure to Duchenne muscular dystrophy (DMD) using an in-utero gene editing formula.
Read MoreImmunologist William Murphy discusses CAR T-cell cancer therapy and his work with Caring Cross, CIRM and UC Davis researchers to find novel cures to leukemia and lymphoma.
Read MoreCIRM awarded UC Davis’ Alpha Stem Cell Clinic an $8 million grant renewal to expand its successful clinical trials operation and advance toward onsite manufacturing of therapies.
Read MoreMichelle and Jeff were excited to build their new family together, but when she received the distressing news that her developing baby was diagnosed with spina bifida, she looked for the best treatment. She was referred to the CuRe trial.
Read MoreThree babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read MoreCardiothoracic surgery resident Nataliya Bahatyrevich has become the latest UC Davis trainee to receive a prestigious T32 federal research grant. The award will allow her to spend a year in the laboratory and pursue a Master of Science in biomedical engineering at UC Davis
Read MoreStem cell researcher Jan Nolta received the Lifetime Achievement Award in Innovation during the 2022 Chancellor’s Innovation Awards ceremony on June 16. The awards recognize faculty, community partners and industry leaders developing innovative solutions to improve the lives of others and address important needs in the global society.
Read MoreProfessor Aijun Wang won $3 million grant from California Institute for Regenerative Medicine to develop a smart durable vascular device for hemodialysis patients treated for kidney failure. The device uses a unique molecule to help prevent synthetic vascular graft failure, a common problem for patients undergoing hemodialysis.
Read More